137 related articles for article (PubMed ID: 24752085)
1. Clinical outcomes of bridging therapy with fondaparinux versus low-molecular-weight heparin in patients undergoing atrial fibrillation ablation.
Zhang F; Zhao D; Peng X; Yang H; Zhu T; Huang F; Peng J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):448-52. PubMed ID: 24752085
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
[TBL] [Abstract][Full Text] [Related]
4. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.
Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.
Page SP; Herring N; Hunter RJ; Withycombe E; Lovell M; Wali G; Betts TR; Bashir Y; Dhinoja M; Earley MJ; Sporton SC; Rajappan K; Schilling RJ
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):585-90. PubMed ID: 24641450
[TBL] [Abstract][Full Text] [Related]
7. Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.
Tapanainen JM; Braunschweig F; Schwieler J; Insulander P; Bastani H; Drca N; Kennebäck G; Sadigh B; Jensen-Urstad M
Scand Cardiovasc J; 2013 Apr; 47(2):109-13. PubMed ID: 23098247
[TBL] [Abstract][Full Text] [Related]
8. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
9. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?
Page SP; Siddiqui MS; Finlay M; Hunter RJ; Abrams DJ; Dhinoja M; Earley MJ; Sporton SC; Schilling RJ
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):265-70. PubMed ID: 21040095
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
12. Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin.
Saad EB; Costa IP; Costa RE; Inácio LA; Slater C; Camiletti A; Moura Neto DG; Maldonado P; Camanho LE; Polanczky CA
Arq Bras Cardiol; 2011 Oct; 97(4):289-96. PubMed ID: 21861038
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
14. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
[TBL] [Abstract][Full Text] [Related]
15. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.
Kiviniemi T; Airaksinen KE; Rubboli A; Biancari F; Valencia J; Lip GY; Karjalainen PP; Weber M; Laine M; Kirchhof P; Schlitt A;
Int J Cardiol; 2015 Mar; 183():105-10. PubMed ID: 25662060
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
18. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
19. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
